The record-breaking SpaceX IPO last week made Elon Musk the world's first trillionaire. It also forced the rocket company, a major U.S. defense and launch contractor, to surface a cap table that, for its first two decades, was hidden in private filings. ProPublica reporters Justin Elliott and Joshua Kaplan obtained a confidential list of those pre-IPO shareholders only after going to court to compel disclosure, and the list, published in partnership with Defense One, shows the company spent years before its public listing accepting capital from investors in mainland China, Hong Kong, Russia, and Qatar.
Most of that foreign money moved through a single U.S. middleman: Tomales Bay Capital, a small firm based in Marin County, California. The investor list, surfaced through litigation, names at least a dozen individuals and entities with addresses in mainland China, Hong Kong, or Russia, with pre-IPO stakes ranging from $800,000 to $40 million acquired between 2018 and 2021. Among the named investors is David Su, co-founder of the Beijing venture firm MPCi, whose ties to Chinese military contractors have been previously documented. An entity linked to the Qatari royal family also took a stake in the same period.
The disclosure lands at an awkward moment for SpaceX. The company, which holds sensitive Pentagon launch and satellite contracts, has publicly barred investors from China and Hong Kong from participating in the IPO itself, a stance Bloomberg reported as the company's own acknowledgment that the concern was real. The private-market years, by contrast, show a far more permissive posture toward foreign capital.
ProPublica's reporting rests on a confidential investor list that became public only through court order. The documents do not allege espionage by any named investor. They do, however, surface a structural fact: a U.S. space and defense supplier with classified-adjacent work accepted capital from investors with documented ties to Chinese state-linked entities while operating in a regulatory space where disclosure obligations did not reach.
There is no explicit U.S. ban on Chinese investment in American military contractors. Investments of this kind are governed by the Committee on Foreign Investment in the United States, known as CFIUS, which can review, unwind, or impose mitigation terms on transactions it deems a national-security risk. U.S. policy, articulated across multiple administrations, has alleged that China uses such investments as a channel for technology access and espionage. That policy frame is a U.S. government allegation, not a finding about any individual named on the SpaceX cap table.
The court-fought list is the structural story. SpaceX spent two decades as a private company, raising capital from a mix that included sovereign-adjacent and state-adjacent foreign money, with no obligation to disclose the full roster. The IPO forces the public market's disclosure rules to apply. A court order was needed to do the same job for the years the company spent as a private one.
For CFIUS, for the Pentagon, and for U.S. public-market investors buying into SpaceX after the listing, the question now is whether the pre-IPO years leave any unresolved national-security exposure, and whether the disclosure gap that defined them will be filled, or simply closed, by the IPO itself.